Crossmark

Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials

Published Online: 2024-06-10

Published Print: 2024-09

Authors

Tungjitviboonkun, Songphol https://orcid.org/0009-0001-9910-6563
Bumrungratanayos, Naharuthai https://orcid.org/0009-0002-4753-7318
Jitwimungsanon, Jedsadakorn

Kheamakulvanich, Thanat

Siramongkholkarn, Smuch
License Information

Text and Data Mining valid from 2024-06-10

Version of Record valid from 2024-06-10
More Information

Article History

Received: 10 April 2024

Accepted: 30 May 2024

First Online: 10 June 2024

Declarations

:

: None to declare.

: The authors declare no competing interests.

Document is current